Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer

ConclusionCompression therapy was the most effective intervention in this phase IIB selection trial to prevent CIPN and was well tolerated. Compression therapy for the prevention of CIPN should be evaluated in a phase III study.Clinical trial registrationClinicaTrials.gov Identifier: NCT03873272.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research